ELEGROBART
UNII XB49Z3T6CY

Substance Identification & Data

This profile provides standardized clinical and technical data for Elegrobart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XB49Z3T6CY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2832924-76-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XB49Z3T6CY

CAS Registry Number

2832924-76-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ELEGROBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C215280

National Cancer Institute reference terminology for clinical and research data.

INN ID

13528

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

OP-70

Identifier assigned by the United States Adopted Names Council.

Substance Type

Elegrobart

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Elegrobart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Elegrobart

Common Names & Synonyms

ELEGROBART [USAN]

Immunoglobulin G1 [96-phenylalanine,de-C-terminal lysine], anti-(human insulin-like growth factor I receptor) (human-Mus musculus monoclonal VRDN-003 γ1-chain), disulfide with human-Mus musculus monoclonal VRDN-003 κ-chain, dimer

elegrobart [INN]

immunoglobulin G1-kappa, anti-[Homo sapiens IGF1R (insulin-like growth factor 1 receptor, IGF1-R, IGF-1R, CD221)], monoclonal antibody; H-gamma1 heavy chain (1-453) [VH Musmus/Homsap (Mus musculus IGHV1-69-5*01 (92.9%) -(IGHD) -IGHJ1*01 (93.8%) A120>Q (116)/Homo sapiens IGHV1-46*01 (77.6%) C104>F (96) -(IGHD) -IGHJ6*01 (100%), CDR-IMGT [8.8.17] (26-33.51-58.97-113)) (1-124) -Homo sapiens IGHG1*01, G1m17,1 CH1 K120, CH3 D12, L14, 9-G1v21 CH2 Y15.1, T16, E18 (CH1 K120 (221) (125-222), hinge 1-15 (223-237), CH2 M15.1>Y (259), S16>T (261), T18>E (263) (238-347), CH3 D12 (363), L14 (365) (348-452), CHS K2>del (453)) (125-453)], (227-219')-disulfide with L-kappa light chain (1'-219') [V-KAPPA Musmus/Homsap (Mus musculus IGKV1-117*01 (93.0%) -IGKJ1*02 (100%)/Homo sapiens IGKV2-30*02 (81.0%) -IGKJ4*01 (90.9%) V124>L (109'), CDR-IMGT [11.3.9] (27'-37'.55'-57'.94'-102')) (1'-112') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (158'), V101 (196')) (113'-219')]; dimer (233-233'':236-236'')-bisdisulfide, produced in a cell line from Chinese hamster ovary (CHO) cells, derived from the cell line CHOK1, glycoform alfa

Technical Codes

VRDN-003

External Clinical & Regulatory Resources

Previous UNIIXB407QGF15

Next UNIIXB4K113EL0